Juridical Foundation The Chemo-Sero-Therapeutic Research Institute obtains United States patent.
Juridical Foundation The Chemo-Sero-Therapeutic Research Institute (Kumamoto-shi, Japan) has patented a gene encoding a protein from merozoite of Babesia caballi, a recombinant protein of Babesia caballi, and an antibody capable specifically binding to a 48 kDa protein of rhoptry of Babesia caballi merozoite. In accordance with the present invention, it is possible to stably prepare the 48 kDa protein of rhoptry of Babesia caballi and the gene encoding said protein in a large amount with the recombinant DNA technique. The present invention also provides a method for diagnosing equine babesiasis which comprises either specifically detecting anti-Babesia caballi antibody present in equine blood by using the recombinant protein of present invention as an antigen or detecting the presence of Babesia caballi merozoite in equine blood by using the antibody of the present invention. (US 7,326,543)
|Printer friendly Cite/link Email Feedback|
|Publication:||BIOTECH Patent News|
|Date:||Jan 1, 2008|
|Previous Article:||Cardica Receives $2 Million Payment From Cook Medical for Successful Completion of Multiple Milestones.|
|Next Article:||Takara Bio obtains United States patent.|